$CRL News

Assessing Charles River Laboratories (CRL) Valuation After Mixed Returns And Contrasting Undervaluation Signals

Charles River Laboratories International, Inc. (CRL) Presents at Jefferies Global Healthcare Conference 2026 Transcript

Charles River Laboratories International, Inc. (CRL) Presents at 46th Annual William Blair Growth Stock Conference - Slideshow

Charles River Laboratories International, Inc. (CRL) Presents at 46th Annual William Blair Growth Stock Conference Transcript

Charles River Laboratories to Present at William Blair and Jefferies Conferences

CLSA Upgrades Charles River Laboratories International (CRL)

CLSA Upgrades Charles River to Outperform, Raises Price Target to $219

Are Wall Street Analysts Bullish on Charles River Laboratories Stock?

Is Charles River (CRL) Quietly Recasting Its Moat Around AI Pathology And Cell Therapy Services?

Charles River Laboratories (CRL) is a Top-Ranked Value Stock: Should You Buy?

Drug Development Inputs & Services Stocks Q1 In Review: Charles River Laboratories (NYSE:CRL) Vs Peers

The 5 Most Interesting Analyst Questions From Charles River Laboratories’s Q1 Earnings Call

NeoGenomics and Charles River Laboratories Shares Plummet, What You Need To Know

[Latest] Global Transgenic Animals Market Size/Share Worth USD 7.89 Billion by 2035 at a 10.1% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Charles River Laboratories and MEDIPOST Sign Non-Exclusive MOU to Advance GMP Testing Solutions

Charles River And MEDIPOST Enter Into Strategic, Non-Exclusive MOU To Collaborate On GMP-Compliant Testing To Advance Cell Therapy Development And Commercialization

CRL Q1 Deep Dive: Portfolio Restructuring and Cost Initiatives Set Stage for Margin Expansion

Charles River (CRL) Reliance on International Sales: What Investors Need to Know

Charles River Accelerates Digital Pathology with AI-Powered End-to-End Workflow

Is It Time To Rethink Charles River Laboratories (CRL) After Its Recent Price Rebound?